NetScientific: refinanced and focused on enhancing value

0
14
  • NetScientific: Broker lifts its price target, but does the City really get story?
NetScientific PLC -

Quick facts: NetScientific PLC

Follow

View company profile

NetScientific PLC is a holding company, that invests in, develops, commercialises and realises shareholder value in life sciences/healthcare, sustainability and technology companies, which offer significant growth potential predominately in the UK and USA, as well as globally.

With the acquisition of EMV Capital in August 2020, the Group doubled its portfolio from 8 to 17 companies, either through direct subsidiary, balance sheet investment or capital under advisory, varying from start-up private companies to publicly listed equities.

30 Sep 2021

A City broker has raised its valuation for shares in (, ), saying the potential of its investment portfolio still isn’t being fully understood or recognised by the market.

It was a topic touched upon in Wednesday’s interim figures: “The board remains of the view that the market significantly undervalues the group, with current price below fair value, but without taking into account growth opportunities.”

On Thursday the stock was trading at 123.6p, which is an almost 10-fold increase from where it was at its nadir in early 2020.

That said, the market capitalisation is currently around GBP25mln, which represents a significant discount to fair value, estimated in the six-month results to be GBP31.9m (up 50% year on year). The net asset value is put at GBP23mln.

Read more

29 Sep 2021

The turnaround at (, ), the investor in life sciences and technology, continues apace.

However, the current share price still doesn’t reflect its inherent worth, let alone its potential, the company said.

Read more

16 Sep 2021

(, ) said it is investing an initial GBP1mln in Martlet Capital, which has been set up to acquire a portfolio of minority interests in growth companies operating in the Cambridge high-tech cluster.

NetScientific’s subsidiary, EMV Capital, co-led a GBP12mln fundraiser, alongside private office Saranac Partners, that will allow Martlet to complete the acquisition of over 50 investments currently held by Marshall of Cambridge.

Read more

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is…

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash…

FOR OUR FULL DISCLAIMER CLICK HERE

NetScientific says results mark ‘end of turnaround period, which has been…

NetScientific PLC (AIM:NSCI, FRA:NTK1) (AIM:NSCI, FRA:NTK1) chief executive, Dr Ilian Iliev joins Proactive to discuss their interim results results and statement.

The results for the six months ended June 30 showed the loss for the period was almost GBP1.5mln, reflecting the investments in…

1 day, 10 hours ago

5 min read

LEAVE A REPLY

Please enter your comment!
Please enter your name here